GREENHAVEN ASSOCIATES INC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0000846222
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Greenhaven Associates — tracked via quarterly SEC 13F filings · All famous investors
Q2 2026 · 28 positions · Total reported value $8.66B · Top-10 concentration 79.1% · Updated 2026-10-24
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
Turnover: 55.2% · 1 new · 13 cut · 2 exited
Active Share (vs S&P 500): 99.5% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -4.3% · vs SPY -6.4% · Prev Value $8.66B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): +7.4% · vs SPY +5.3% · Latest Value $7.96B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q2 2026 13F filing, GREENHAVEN ASSOCIATES INC disclosed 28 equity positions with a combined reported value of $8.66B. The filing implies a focused portfolio: its ten largest positions account for 79.1% of reported value. HoldingsHub classifies the profile as Mid / Focused / Consumer Tilt / High Turnover.
The largest disclosed positions as of Q2 2026 were LEN ($1.02B), GM ($992.29M), TOL ($927.56M). By sector, the heaviest allocations are Consumer Discretionary 48.0%, Health Care 21.4%. Versus the prior quarter, allocation shifted toward Health Care (+13.8pp) and away from Other (-1.3pp), Energy (-1.9pp).
Versus the prior quarter, GREENHAVEN ASSOCIATES INC opened 1 new positions, trimmed 13 and fully exited 2, a turnover rate of 55.2% of positions. The portfolio's overlap with the prior quarter was 77% of names.
The largest new positions opened in Q2 2026 were BDX ($859.81M), ACN ($421.19M), IQV ($148.40M).
Of the 2 positions fully exited versus the prior quarter, the largest were TMHC ($15.76M), TEX ($645.49K), STLA ($262.33K).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2026)
Insider Transactions (Form 4)
Latest Greenhaven Associates buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Greenhaven Associates, based in Purchase, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 28 positions worth $8.66B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: PURCHASE, NY, United States
- SEC registration: 801-31678 (status: Approved), registered 1988-03-18
- Regulatory AUM (Form ADV): $11.66B as of 2026-02-10
- Client mix (by RAUM): individual investors 97%, pension and profit-sharing plans 3%
Portfolio Structure
- 28 positions · $8.66B reported value (Q2 2026)
- Top 10 holdings = 79.1% of reported value
- Largest position: LEN (LENNAR CORP) at 11.8%
- Average position size: $309.31M
Sector Tilt
- Consumer Discretionary 48.0%
- Health Care 21.4%
- Industrials 18.9%
- (classified holdings cover 99% of value)
Quarterly Activity
- Q2 2026: 4 new, 7 added, 9 reduced, 3 exited
- 8 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
11.32M | $1.02B | 11.82% | Add | |
| 2 |
|
12.87M | $992.29M | 11.46% | Add | |
| 3 |
|
5.63M | $927.56M | 10.71% | Hold | |
| 4 |
|
5.68M | $859.81M | 9.93% | New | |
| 5 |
|
5.46M | $748.61M | 8.64% | Reduce | |
| 6 |
|
3.51M | $571.02M | 6.59% | Add | |
| 7 |
|
3.10M | $538.61M | 6.22% | Add | |
| 8 |
|
3.38M | $421.19M | 4.86% | New | |
| 9 |
|
2.56M | $392.71M | 4.53% | Add | |
| 10 |
|
1.76M | $376.49M | 4.35% | Reduce | |
| 11 |
|
3.77M | $335.11M | 3.87% | Reduce | |
| 12 |
|
14.29M | $304.56M | 3.52% | Hold | |
| 13 |
|
24.64M | $243.91M | 2.82% | Add | |
| 14 |
|
1.46M | $195.18M | 2.25% | Reduce | |
| 15 |
|
3.80M | $176.77M | 2.04% | Reduce | |
| 16 |
|
768.04K | $148.40M | 1.71% | New | |
| 17 |
|
1.30M | $108.79M | 1.26% | Reduce | |
| 18 |
|
5.62M | $104.25M | 1.20% | Reduce | |
| 19 |
|
4.34M | $56.34M | 0.65% | Add | |
| 20 |
|
662.00K | $50.10M | 0.58% | Reduce | |
| 21 |
|
587.30K | $46.60M | 0.54% | New | |
| 22 |
|
364.06K | $32.30M | 0.37% | Hold | |
| 23 |
|
17.50K | $1.87M | 0.02% | Hold | |
| 24 |
|
10.70K | $1.42M | 0.02% | Hold | |
| 25 |
|
12.50K | $1.15M | 0.01% | Hold | |
| 26 |
|
2.50K | $818.33K | 0.01% | Reduce | |
| 27 |
|
2.03K | $552.70K | 0.01% | Hold | |
| 28 |
|
10.00K | $275.00K | 0.00% | Hold | |
FAQ
What did GREENHAVEN ASSOCIATES INC buy in 2026-Q2?
In its 2026-Q2 13F filing, GREENHAVEN ASSOCIATES INC reported 28 equity positions worth $8.66B in aggregate; its largest disclosed positions were LEN ($1.02B), GM ($992.29M), TOL ($927.56M).
How large is GREENHAVEN ASSOCIATES INC's portfolio?
GREENHAVEN ASSOCIATES INC reported $8.66B of long equity holdings across 28 positions as of 2026-Q2. Top-10 holdings account for 79.1% of reported value.
What is GREENHAVEN ASSOCIATES INC's investment style?
HoldingsHub classifies the portfolio as Mid / Focused / Consumer Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.